Cargando…

Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative

INTRODUCTION: Analyses of off‐label use of acetylcholinesterase inhibitors (AChEIs) in mild cognitive impairment (MCI) has produced mixed results. Post hoc analyses of observational cohorts, such as the Alzheimer's Disease Neuroimaging Initiative (ADNI), have reported deleterious effects in ACh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stage, Eddie, Svaldi, Diana, Sokolow, Sophie, Risacher, Shannon L., Marosi, Krisztina, Rotter, Jerome I., Saykin, Andrew J., Apostolova, Liana G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719350/ https://www.ncbi.nlm.nih.gov/pubmed/35005201 http://dx.doi.org/10.1002/trc2.12168

Ejemplares similares

Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis
por: Stage, Eddie C., et al.
Publicado: (2020)

Association of the top 20 Alzheimer's disease risk genes with [(18)F]flortaucipir PET
por: Stage, Eddie, et al.
Publicado: (2022)

The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism
por: Stage, Eddie, et al.
Publicado: (2016)

Optimizing differential identifiability improves connectome predictive modeling of cognitive deficits from functional connectivity in Alzheimer's disease
por: Svaldi, Diana O., et al.
Publicado: (2021)

Characterization of gene expression patterns in mild cognitive impairment using a transcriptomics approach and neuroimaging endophenotypes
por: Bharthur Sanjay, Apoorva, et al.
Publicado: (2022)

Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer's disease biomarker amyloid β1-42 in Alzheimer's Disease Neuroimaging Initiative participants
por: Li, Wei, et al.
Publicado: (2017)

NEUROLOGICAL CORRELATES OF SOCIAL BONDING AND BRIDGING
por: Manchella, Mohit, et al.
Publicado: (2022)

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
por: Risacher, Shannon L., et al.
Publicado: (2019)

Temporal stability of the ventral attention network and general cognition along the Alzheimer’s disease spectrum
por: Chumin, Evgeny J., et al.
Publicado: (2021)

Introduction to special edition, “State of the Field: Advances in Neuroimaging from the 2016 Alzheimer's Imaging Consortium”
por: Mormino, Elizabeth C., et al.
Publicado: (2016)

Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography
por: Risacher, Shannon L., et al.
Publicado: (2017)

Deep learning detection of informative features in tau PET for Alzheimer’s disease classification
por: Jo, Taeho, et al.
Publicado: (2020)

Predicting the Emergence of Major Neurocognitive Disorder Within Three Months After a Stroke
por: Aamodt, Eva Birgitte, et al.
Publicado: (2021)

Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
por: Hirschfeld, Lauren Rose, et al.
Publicado: (2022)

Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer’s disease
por: Nho, Kwangsik, et al.
Publicado: (2017)

Cholinesterase inhibitors as Alzheimer's therapeutics
por: Sharma, Kamlesh
Publicado: (2019)

White matter alterations in early-stage Alzheimer's disease: A tract-specific study
por: Wen, Qiuting, et al.
Publicado: (2019)

Cognitive biomarker prioritization in Alzheimer’s Disease using brain morphometric data
por: Peng, Bo, et al.
Publicado: (2020)

Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease
por: Zimmer, Jennifer A., et al.
Publicado: (2021)

Memory concerns in the early Alzheimer's disease prodrome: Regional association with tau deposition
por: Swinford, Cecily G., et al.
Publicado: (2018)

Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study
por: Swaminathan, Shanker, et al.
Publicado: (2011)

Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease
por: Vasanthakumar, Aparna, et al.
Publicado: (2020)

Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition
por: Risacher, Shannon L, et al.
Publicado: (2020)

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
por: Nho, Kwangsik, et al.
Publicado: (2019)

Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia
por: Hoffmann, Falk, et al.
Publicado: (2011)

Deep Learning in Alzheimer's Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data
por: Jo, Taeho, et al.
Publicado: (2019)

Resting state network modularity along the prodromal late onset Alzheimer's disease continuum
por: Contreras, Joey A., et al.
Publicado: (2019)

Tau-related white-matter alterations along spatially selective pathways
por: Wen, Qiuting, et al.
Publicado: (2020)

Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease
por: Hu, Ziheng, et al.
Publicado: (2018)

Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer’s disease neuroimaging initiative
por: Yao, Xiaohui, et al.
Publicado: (2017)

Association of cancer history with Alzheimer's disease onset and structural brain changes
por: Nudelman, Kelly N. H., et al.
Publicado: (2014)

Identification of exon skipping events associated with Alzheimer’s disease in the human hippocampus
por: Han, Seonggyun, et al.
Publicado: (2019)

Genetic variation affecting exon skipping contributes to brain structural atrophy in Alzheimer’s disease
por: Lee, Younghee, et al.
Publicado: (2018)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

Genome-Wide Association Analysis across Endophenotypes in Alzheimer’s Disease: Main Effects and Disease Stage-Specific Interactions
por: Rosewood, Thea J., et al.
Publicado: (2023)

Integrative analysis of eQTL and GWAS summary statistics reveals transcriptomic alteration in Alzheimer brains
por: Varathan, Pradeep, et al.
Publicado: (2022)

Hippocampal transcriptome-guided genetic analysis of correlated episodic memory phenotypes in Alzheimer's disease
por: Yan, Jingwen, et al.
Publicado: (2015)

Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
por: Swaminathan, Shanker, et al.
Publicado: (2011)

Response to cholinesterase inhibitors affects lifespan in Alzheimer’s disease
por: Wattmo, Carina, et al.
Publicado: (2014)

The comparative efficacy and safety of cholinesterase inhibitors in patients with mild‐to‐moderate Alzheimer's disease: a Bayesian network meta‐analysis
por: Kobayashi, Hisanori, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l69mj6t992klrcl12k0sjalamd